UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic bacterial prostatitis with microbiological diagnosis: a report of two cases

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2024, Vol.37 (1), p.118-120

2024

Volltextzugriff (PDF)

Chronic bacterial prostatitis with microbiological diagnosis: a report of two cases

Revista española de quimioterapia, 2023-12

2023

Volltextzugriff (PDF)

Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: a population-based study

BMJ open respiratory research, 2023-01, Vol.10 (1), p.e001468

2023

Volltextzugriff (PDF)

A compound directed against S6K1 hampers fat mass expansion and mitigates diet-induced hepatosteatosis

JCI insight, 2022-07, Vol.7 (14)

2022

Volltextzugriff (PDF)

Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery

BJS open, 2021-11, Vol.5 (6)

2021

Volltextzugriff (PDF)

C-reactive protein at ICU admission as a marker of early graft dysfunction after liver transplant. A prospective, single-center cohort study

Medicina intensiva, 2020-06, Vol.44 (5), p.275-282

2020

Volltextzugriff (PDF)

Early graft dysfunction after liver transplant: Comparison of different diagnostic criteria in a single-center prospective cohort

Medicina intensiva, 2020-04, Vol.44 (3), p.150-159

2020

Volltextzugriff (PDF)

EP1.10-04 Characteristics of Smoker Patients with Lung Cancer in the Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S1007-S1007

2019

Volltextzugriff (PDF)

Characteristics of Smoker Patients with Lung Cancer in the Lung Cancer: EP1.10-04

Journal of thoracic oncology, 2019-10, Vol.14 (10 Suppl), p.S1007-S1007

2019

Volltextzugriff (PDF)

PL02.09 Nintedanib + Pemetrexed/Cisplatin in Patients with Unresectable MPM: Phase III Results from the LUME-Meso Trial

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S186-S186

2018

Volltextzugriff (PDF)

PO-085 MiR-424(322)/503 regulates Wnt/b-catenin pathway and resistance to treatment in breast cancer

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A54-A54

2018

Volltextzugriff (PDF)

Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study

Respiratory research, 2017-12, Vol.18 (1), p.200-200, Article 200

2017

Volltextzugriff (PDF)

P1.09-011 LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients with Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2021-S2022

2017

Volltextzugriff (PDF)

Relationship between functional status prior to onset of critical illness and mortality: A prospective multicentre cohort study

Anaesthesia and intensive care, 2017-05, Vol.45 (3), p.351-358

2017

Volltextzugriff (PDF)

Abstract S1-06: The miR-424/503 cluster is a breast cancer tumor suppressor with a role in chemoresistance

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S1-S1-06

2016

Volltextzugriff (PDF)

Abstract PD3-03: Inhibition of the autocrine IL6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.PD3-03-PD3-03

2016

Volltextzugriff (PDF)

Evaluation of saps-3 index in patients whith structural brain lesion admitted in intensive care unit (ICU)

Intensive care medicine experimental, 2015-10, Vol.3 (Suppl 1), p.1, Article A833

2015

Volltextzugriff (PDF)

Effect of Nintedanib (Bibf 1120) Combined with Standard 2Nd-Line Docetaxel in Nsclc Patients Who Received Prior Pemetrexed in Lume-Lung 1: a Randomised, Placebo-Controlled Phase III Trial

Annals of oncology, 2014-09, Vol.25, p.iv157

2014

Volltextzugriff (PDF)

Prior Taxane Use in the Lume-Lung 1 Phase III Trial and the Effect on Outcome Following 2Nd-Line Treatment with Nintedanib (Bibf 1120) and Docetaxel in Patients with Advanced Nsclc

Annals of oncology, 2014-09, Vol.25, p.iv158

2014

Volltextzugriff (PDF)

473PPRIOR TAXANE USE IN THE LUME-LUNG 1 PHASE III TRIAL AND THE EFFECT ON OUTCOME FOLLOWING 2ND-LINE TREATMENT WITH NINTEDANIB (BIBF 1120) AND DOCETAXEL IN PATIENTS WITH ADVANCED NSCLC

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv158-iv158

2014

Volltextzugriff (PDF)

471PEFFECT OF NINTEDANIB (BIBF 1120) COMBINED WITH STANDARD 2ND-LINE DOCETAXEL IN NSCLC PATIENTS WHO RECEIVED PRIOR PEMETREXED IN LUME-LUNG 1: A RANDOMISED, PLACEBO-CONTROLLED PHASE III TRIAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv157-iv157

2014

Volltextzugriff (PDF)

External validation of the Simplified Acute Physiology Score (SAPS) 3 in Spain

Medicina intensiva (English ed.), 2014-06, Vol.38 (5), p.288-296

2014

Volltextzugriff (PDF)

External validation of the Simplified Acute Physiology Score (SAPS) 3 in Spain

Medicina intensiva, 2014-06, Vol.38 (5), p.288-296

2014

Volltextzugriff (PDF)

30 Nintedanib (BIBF 1120) + docetaxel as second-line therapy in patients with stage IIIB/IV or recurrent NSCLC: results of the phase III, randomised, double-blind LUME-Lung 1 trial

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S12-S12

2014

Volltextzugriff (PDF)

Declive y regionalización de la matrícula salmantina de los siglos XVII y XVIII. Aproximación descriptiva

Studia historica. Ha. moderna, 2009-12, Vol.3

2009

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Humans
(22)
Biological And Medical Sciences
(19)
Male
(13)
Female
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Aged
(9)
Animals
(9)
Middle Aged
(9)
Adult
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(8)
Antineoplastic Agents
(7)
General Aspects
(7)
Spain
(7)
Biological Transport
(6)
Ecology
(6)
Environmental Sciences & Ecology
(6)
Mice
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chronic bacterial prostatitis with microbiological diagnosis: a report of two cases

Chronic bacterial prostatitis with microbiological diagnosis: a report of two cases

Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: a population-based study

A compound directed against S6K1 hampers fat mass expansion and mitigates diet-induced hepatosteatosis

Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery

C-reactive protein at ICU admission as a marker of early graft dysfunction after liver transplant. A prospective, single-center cohort study

Early graft dysfunction after liver transplant: Comparison of different diagnostic criteria in a single-center prospective cohort

EP1.10-04 Characteristics of Smoker Patients with Lung Cancer in the Lung Cancer

Characteristics of Smoker Patients with Lung Cancer in the Lung Cancer: EP1.10-04

PL02.09 Nintedanib + Pemetrexed/Cisplatin in Patients with Unresectable MPM: Phase III Results from the LUME-Meso Trial

PO-085 MiR-424(322)/503 regulates Wnt/b-catenin pathway and resistance to treatment in breast cancer

Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study

P1.09-011 LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients with Malignant Pleural Mesothelioma

Relationship between functional status prior to onset of critical illness and mortality: A prospective multicentre cohort study

Abstract S1-06: The miR-424/503 cluster is a breast cancer tumor suppressor with a role in chemoresistance

Abstract PD3-03: Inhibition of the autocrine IL6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers

Evaluation of saps-3 index in patients whith structural brain lesion admitted in intensive care unit (ICU)

Effect of Nintedanib (Bibf 1120) Combined with Standard 2Nd-Line Docetaxel in Nsclc Patients Who Received Prior Pemetrexed in Lume-Lung 1: a Randomised, Placebo-Controlled Phase III Trial

Prior Taxane Use in the Lume-Lung 1 Phase III Trial and the Effect on Outcome Following 2Nd-Line Treatment with Nintedanib (Bibf 1120) and Docetaxel in Patients with Advanced Nsclc

473PPRIOR TAXANE USE IN THE LUME-LUNG 1 PHASE III TRIAL AND THE EFFECT ON OUTCOME FOLLOWING 2ND-LINE TREATMENT WITH NINTEDANIB (BIBF 1120) AND DOCETAXEL IN PATIENTS WITH ADVANCED NSCLC

471PEFFECT OF NINTEDANIB (BIBF 1120) COMBINED WITH STANDARD 2ND-LINE DOCETAXEL IN NSCLC PATIENTS WHO RECEIVED PRIOR PEMETREXED IN LUME-LUNG 1: A RANDOMISED, PLACEBO-CONTROLLED PHASE III TRIAL

External validation of the Simplified Acute Physiology Score (SAPS) 3 in Spain

External validation of the Simplified Acute Physiology Score (SAPS) 3 in Spain

30 Nintedanib (BIBF 1120) + docetaxel as second-line therapy in patients with stage IIIB/IV or recurrent NSCLC: results of the phase III, randomised, double-blind LUME-Lung 1 trial

Declive y regionalización de la matrícula salmantina de los siglos XVII y XVIII. Aproximación descriptiva

Suchergebnisse filtern